Bevacizumab in Metastatic Renal Cancer

Clinical trial NCT02627144 · COMPLETED

Trial details

NCT number: NCT02627144
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Cancer

Start date: 2008-01-01
Primary completion: 2014-09-01
Enrollment: 365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.